A company with a business unit which was marketing an antibody-directed technology platform was realizing that customers were asking for a broader usability of the technology.
FHR Consult analyzed the technology, current offerings and customer requests. It became clear that a strategic partnership rather than further in-house development would be best suited to meet such customer demand.
FHR Consult identified a large CMO as the best partner, initiated discussions and provided negotiation support. This led to a strategic development and marketing agreement which broadened the technology base and increased customer number.
Learn more about our services for biotech, pharmaceutical and medtech companies and investors.